Haematology 2018

First page Table of contents Previous page 714 Next page Last page

Response Rates and Progression-free Survival with Obinutuzumab–Chlorambucil versus Rituximab–Chlorambucil.

Made with FlippingBook - professional solution for displaying marketing and sales documents online